Semaglutide and tirzepatide are changing medicine — not just for obesity, but for cardiovascular disease, fatty liver, dementia risk, and longevity. What we know and what it means for your health.
Every post is written by physicians or the Mt. Baker Medical clinical team and reviewed by Dr. James Scribner, MD, FACEP — A4M Fellow and board-certified emergency physician. Sources are linked inline where possible; recommendations reflect current evidence and clinical practice.
